Latest News and Press Releases
Want to stay updated on the latest news?
-
4D Path QPORTM platform delivers unprecedented predictive insights for patients with low immune infiltrates—achieving a 66% response rate
-
Renowned experts in oncology and pathology join forces on 4D Path SAB to accelerate the impact of digital treatment prediction biomarkers